Clinical analysis of invasive laryngeal mycosis.
- Author:
Dazhi SHI
;
Zhiqiang LUO
- Publication Type:Journal Article
- MeSH:
Administration, Oral;
Amphotericin B;
therapeutic use;
Antifungal Agents;
therapeutic use;
Chemical and Drug Induced Liver Injury;
prevention & control;
Fluconazole;
therapeutic use;
Humans;
Itraconazole;
therapeutic use;
Laryngeal Diseases;
drug therapy;
etiology;
pathology;
Mycoses;
drug therapy;
etiology;
pathology
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2013;27(21):1174-1176
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To summarize the clinical datas of thepatients with invasive laryngeal fungal infections in, discuss pathogenesis and treatment methods.
METHOD:Eleven cases of invasive laryngeal fmycosis who were collected from September 2006 to February 2010 with electronic laryngoscopy, aspirate smear and culture and tissue biopsy for pathological diagnosis, were restrospectively analyzed. Those patients were received iv fluconazole, treatment of Oxygen Atomization of amphotericin B solution and taking itraconazole orally. The hepatic and renal functions of the patients were monitored in the course of treatment.
RESULT:All the cases were diagnosed of invasive laryngeal mycosis. 1 patient showed liver dysfunction in the second week during treatment. And continuing the treatment after using liver protection drugs. All symptoms of the patients were improved and no recurrence happened during the 1-6 years of follow-up.
CONCLUSION:Invasive laryngeal fmycosis was correlated with occupation exposure, abusing of antibiotics and low immunity. Laryngeal mycosis was Diagnosised mainly depended on the pathological examination. The positive rates of the secretion smear was low. The effects of iv fluconazole, Oxygen Atomization of amphotericin B 2-4 weeks, and 4 weeks of taking itraconazole orally were safety and reliable.
